Abstract
The classification of most tumors results from an interaction between pathologists, oncologists, and the surgeon often aided by a tissue biopsy. Retinoblastoma is unique among childhood malignancies in that a direct biopsy is not done for diagnosis and currently classification is based on clinical features only. Additionally, for solid childhood malignancies, survival of the patient is generally the sole endpoint to measure therapeutic efficacy. However, in retinoblastoma, effective salvage of the globe is another critical and clinically relevant endpoint. For this reason group classifications for retinoblastoma are often tumor classifications; to be successful, they must reflect clinical reality and must be updated as the treatments change.
Similar content being viewed by others
References
Reese AB, Ellsworth RM. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164–72.
Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18(1):41–53.
Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801–5.
Murphree ALC, G.L. The staging and grouping of intraocular retinoblastoma. In: ADB S, Pe’er J, editors. Clinical ophthalmic oncology. Philadelphia: Elsevier; 2007. p. 422–7.
Berman JJ. Tumor classification: molecular analysis meets Aristotle. BMC Cancer. 2004;4:10.
Fleming ID. Staging of pediatric cancers: problems in the development of a national system. Semin Surg Oncol. 1992;8(2):94–7.
Mallipatna A. AJCC cancer staging manual. 8th ed. Springer; 2017.
Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children’s Hospital Los Angeles experience. Br J Ophthalmol. 2014;98(8):1061–5.
Kim JW, Aziz HA, McGovern K, Zolfaghari E, Jubran RF, Murphree AL, et al. Treatment outcomes of focal laser consolidation during chemoreduction for Group B retinoblastoma. Ophthalmol Retina. 2017;1(5):361–8.
Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, et al. Long-term outcomes of Group B eyes in patients with retinoblastoma treated with short-course chemoreduction: experience from Children’s Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015;2(2):105–11.
Berry JL, Jubran R, Kim JW, Wong K, Bababeygy SR, Almarzouki H, et al. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage. Pediatr Blood Cancer. 2013;60(4):688–93.
Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276–80.
Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17(3):228–34.
Kim JW, Shah SN, Green S, O’Fee J, Tamrazi B, Berry JL. Tumor size criteria for Group D and E eyes in the International Classification System for Retinoblastoma: effects on rates of globe salvage and high-risk histopathologic features. Acta Ophthalmologica 2020; 98(1):e121–125.
Pratt CB, Fontanesi J, Lu X, Parham DM, Elfervig J, Meyer D. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist. 1997;2(1):1–5.
Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1(4):721–35.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Berry, J.L. (2021). Staging and Grouping of Retinoblastoma. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_267-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-90495-5_267-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90495-5
Online ISBN: 978-3-319-90495-5
eBook Packages: Springer Reference MedicineReference Module Medicine